Advertisement

Document › Details
UCB S.A.. (4/25/18). "Press Release: UCB First Three Months Interim Report 2018. UCB Tracking Well towards Full Year Financial Outlook". Brussels.
![]() |
Organisation | UCB S.A. (Euronext: UCB) |
Group | UCB (Group) | |
Organisation 2 | Element Genomics Inc. | |
Group | UCB (Group) | |
![]() |
Product | Cimzia® |
Product 2 | UCB0107 (UCB) | |
![]() |
Index term | Element Genomics–UCB: investment, 201804 acquisition by UCB for up to $30m in upfront + short-term milestones |
![]() |
Person | Tellier, Jean-Christophe (201403– CEO-elect joined UCB 2011 before Ipsen + Macrogenics + Novartis) |
Person 2 | Witte, Antje (UCB 201601 Investor Relations) | |
Original document
accessed by [iito] on 2018-04-29
Record changed: 2018-05-01 |
Advertisement

More documents for UCB (Group)
- [1] UCB S.A.. (1/13/21). "Press Release: UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy". Brussels & Atlanta, GA....
- [2] Swedish Orphan Biovitrum AB. (12/21/20). "Press Release: Sobi Appoints New Head of North America Ahead of Launch Phase"....
- [3] Locanabio, Inc.. (12/14/20). "Press Release: Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNATargeted Gene Therapies for Neurodegenerative, Neuromuscular and Retinal Diseases". San Diego, CA....
- [4] UCB S.A.. (11/12/20). "Press Release: UCB Strengthens Its Gene Therapy Activities with Additional Pipeline Programs, Capabilities and Platforms". Brussels....
- [5] UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels....
- [6] CRISPR Therapeutics AG. (2/26/20). "Press Release: CRISPR Therapeutics Proposes Changes to the Board of Directors". Zug & Cambridge, MA....
- [7] UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA....
- [8] Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield....
- [9] UCB S.A.. (4/9/19). "Press Release: FDA Approves Evenity (Romosozumab) for the Treatment Of Osteoporosis in Postmenopausal Women at High Risk for Fracture". Brussels....
- [10] UCB S.A.. (3/1/19). "Press Release: New Data Affirms Strength of UCB Immuno-Dermatology Portfolio". Brussels....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top